MATHIAS LICHTERFELD, MD
Osteopathic Medicine at Fruit St, Boston, MA

License number
Massachusetts 234808
Category
Osteopathic Medicine
Type
Infectious Disease
License number
Massachusetts 234808
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
55 Fruit St, Boston, MA 02114
Phone
(617) 724-6620

Personal information

See more information about MATHIAS LICHTERFELD at radaris.com
Name
Address
Phone
Mathias Lichterfeld
6 Blackwood St, Boston, MA 02115
(617) 291-4647
Mathias Lichterfeld
30 Garrison St, Boston, MA 02116
(617) 670-1815
Mathias Lichterfeld
346 North St, Boston, MA 02113
(617) 371-1227
Mathias Lichterfeld
6 Blackwood St, Boston, MA 02115
(617) 267-1227
Mathias Lichterfeld
346 North St, Boston, MA 02113
(617) 371-1227

Organization information

See more information about MATHIAS LICHTERFELD at bizstanding.com

Mathias Lichterfeld MD

55 Fruit St, Boston, MA 02114

Industry:
Internist
Phone:
(617) 726-2000 (Phone)
Mathias Lichterfeld

Professional information

See more information about MATHIAS LICHTERFELD at trustoria.com
Mathias Lichterfeld Photo 1
Assistant Professor Of Medicine At Massachusetts General Hospital

Assistant Professor Of Medicine At Massachusetts General Hospital

Position:
Assistant Professor of Medicine at Massachusetts General Hospital
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Massachusetts General Hospital since Jul 2012 - Assistant Professor of Medicine MGH Jul 2010 - Jun 2012 - Instructor in Medicine


Mathias Lichterfeld Photo 2
Mathias Lichterfeld, Boston MA

Mathias Lichterfeld, Boston MA

Specialties:
Internist
Address:
55 Fruit St, Boston, MA 02114
Education:
University of Heidelberg, Faculty of Medicine - Doctor of Medicine*
Massachusetts General Hospital - Fellowship - Infectious Disease (Internal Medicine)*
Massachusetts General Hospital - Residency - Internal Medicine*
Massachusetts General Hospital - Internship - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)*


Mathias Lichterfeld Photo 3
Dr. Mathias Lichterfeld, Boston MA - MD (Doctor of Medicine)

Dr. Mathias Lichterfeld, Boston MA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Age:
49
Address:
100 Blossom St SUITE 515, Boston 02114
(617) 724-9248 (Phone), (617) 726-7653 (Fax)
55 Fruit St, Boston 02114
(617) 724-6620 (Phone), (617) 726-7416 (Fax)
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-8705 (Phone), (617) 724-2710 (Fax)
MASSACHUSETTS GENERAL HOSPITAL DIVISION OF INFECTI
100 Blossom St, Boston 02114
(617) 724-9248 (Phone), (617) 726-7653 (Fax)
Certifications:
Infectious Disease, 2011, Internal Medicine, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
100 Blossom St SUITE 515, Boston 02114
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL DIVISION OF INFECTI
100 Blossom St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
U Heidelberg
Massachusetts General Hospital
MGH/BWH


Mathias Lichterfeld Photo 4
Mathias Lichterfeld, Boston MA

Mathias Lichterfeld, Boston MA

Specialties:
Internal Medicine, Infectious Disease
Work:
Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
Education:
Ruprecht-Karls-Universitaet Heidelberg (2000)


Mathias Lichterfeld Photo 5
Soluble Virus-Specific T-Cell Receptor Compositions

Soluble Virus-Specific T-Cell Receptor Compositions

US Patent:
2008001, Jan 17, 2008
Filed:
Apr 5, 2007
Appl. No.:
11/784277
Inventors:
Mathias Lichterfeld - Boston MA, US
Xu Yu - Boston MA, US
Bruce Walker - Nahant MA, US
Marcus Altfeld - Arlington MA, US
Georg Lauer - Somerville MA, US
International Classification:
A61K 38/00, A61P 43/00, C07H 21/04, C07K 14/00, C12Q 1/70
US Classification:
514002000, 435005000, 530326000, 530327000, 530328000, 536023500
Abstract:
Compositions and methods for diagnosing a viral infection and methods of inhibiting such an infection are described. The methods are based on the identification of T-cell receptor gene sequences from cytotoxic T cell clones that are specific for HIV-1 or HCV. Soluble T-cell receptor compositions that bind to HLA class I-restricted of HIV and HCV pathogens were identified and constructed.